Hiroshi Kida - Infectious Diseases

Author Information

Hiroshi Kida is a distinguished researcher affiliated with the Research Center for Zoonosis Control at Hokkaido University in Sapporo, Japan, as well as the Global Station for Zoonosis Control at the Global Institution for Collaborative Research and Education (GI-CoRE) at Hokkaido University. Additionally, he is associated with the Collaborating Research Center for the Control of Infectious Diseases at Nagasaki University in Nagasaki, Japan. His extensive work focuses on infectious diseases, with a particular emphasis on zoonotic diseases and influenza viruses.

Research Contributions

Hiroshi Kida has contributed significantly to the field of infectious diseases, specifically in the study of influenza viruses and zoonotic pathogens. His work includes investigations into the efficacy of antiviral drugs such as Baloxavir Marboxil against highly pathogenic avian influenza viruses, the development and selection of appropriate influenza vaccines, and the study of abnormal blood coagulation and organ damage related to SARS-CoV-2 infections. His research also extends to understanding the propagation mechanisms of influenza viruses in different environments and developing resources for pandemic preparedness, as seen in his efforts to update the influenza virus library at Hokkaido University.

Aliases

Hiroshi Kida is also known by the aliases H Kida and H. Kida.

Publication and Citation Metrics

Metric	Value
Citation Count	16,077
H-index	58
Paper Count	470

Publications:

Leptospira Is an Environmental Bacterium That Grows in Waterlogged Soil

DOI: 10.1128/spectrum.02157-21

Year: 2022

Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection

DOI: 10.3390/v14010111

Year: 2022

Characterization of the in Vitro and in Vivo Efficacy of Baloxavir Marboxil against h5 Highly Pathogenic Avian Influenza Virus Infection

DOI: 10.20944/preprints202111.0184.v2

Year: 2022

Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against the H5 Highly Pathogenic Avian Influenza Virus Infection

DOI: 10.20944/preprints202111.0184.v1

Year: 2021

Selecting and Using the Appropriate Influenza Vaccine for Each Individual

DOI: 10.3390/v13060971

Year: 2021

Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2

DOI: 10.3390/v13112137

Year: 2021

Sulfated glycans containing NeuAcα2-3Gal facilitate the propagation of human H1N1 influenza A viruses in eggs.

DOI: 10.1016/j.virol.2021.06.008

Year: 2021

Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.

DOI: 10.1016/j.virol.2021.02.005

Year: 2021

Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.

DOI: 10.1016/j.vaccine.2021.05.065

Year: 2021

Genome-wide association study reveals putative bacterial risk factors for cavitary Mycobacterium avium complex lung disease

DOI: 10.1101/2021.07.06.451401

Year: 2021

What Certifications are Necessary?

Can Artemisinin Be Used for Other Infectious Diseases?

What is the Impact of Schistosomiasis Globally?

What Are Antibiotics and How Do They Work?

What are the controversies surrounding Dengvaxia?

How Do Pathogens Invade Hosts?

What are Some Disorders Involving B Cells?

How is Salmonella Transmitted?

How Do Epidemiologists Track Infectious Diseases?

How Can Hepatitis B be Prevented?

Partnered Content Networks

Relevant Topics